The test is now ordered by breast surgeons or radiation oncologists in more than 85% of the top 50 U.S. cancer centers.

Some experts believe the cancer label can be inappropriate for certain low-risk conditions and advocate dropping the C-word.

In non-low-risk DCIS of the breast, the addition of a TBB of radiation following postoperative WBI is associated with reduced local recurrence.

A newly released study is challenging the way doctors commonly treat patients with ductal carcinoma in situ (DCIS), known as stage zero breast cancer. DCIS cancer cells are confined inside a milk duct ...

Understand the key factors influencing breast cancer recurrence and discover effective treatments and lifestyle changes that lower your risk.

Ductal carcinoma in situ (DCIS) is a non-invasive breast condition found in nearly 20% of breast cancer diagnoses, but a growing number of doctors and medical experts are questioning whether the term ...

Innovative smart pill bottles significantly enhance adherence to oral adjuvant endocrine therapy in early-stage breast cancer ...

Watch and wait may be an alternative to surgery for some women with a very early form of breast cancer. A new study of 957 women evaluated whether it was safe to do active monitoring of a low-risk ...

Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen treatment burdens. One new study published in the New England Journal of ...

Please provide your email address to receive an email when new articles are posted on . Lobular breast cancer would be the seventh most common malignancy among women in the U.S. if ranked separately ...

A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, "significantly ...